Cel-Sci
CVM
#9766
Rank
โ‚น4.63 B
Marketcap
โ‚น579.44
Share price
2.54%
Change (1 day)
-59.27%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of June 2025 : โ‚น0.16 Billion

According to Cel-Sci 's latest financial reports the company has โ‚น0.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30โ‚น0.39 B15.18%
2023-09-30โ‚น0.34 B-81.31%
2022-09-30โ‚น1.84 B-41.12%
2021-09-30โ‚น3.13 B174.2%
2020-09-30โ‚น1.14 B90.86%
2019-09-30โ‚น0.59 B-19.88%
2018-09-30โ‚น0.74 B383.06%
2017-09-30โ‚น0.15 B-20.66%
2016-09-30โ‚น0.19 B-48.02%
2015-09-30โ‚น0.37 B-28.7%
2014-09-30โ‚น0.52 B20111.06%
2013-09-30โ‚น2.6 M-98.75%
2012-09-30โ‚น0.20 B-0.42%
2011-09-30โ‚น0.20 B-82.33%
2010-09-30โ‚น1.18 B-26.12%
2009-09-30โ‚น1.60 B3676.28%
2008-09-30โ‚น42.43 M-90.27%
2007-09-30โ‚น0.43 B17.86%
2006-09-30โ‚น0.36 B329.9%
2005-09-30โ‚น86.06 M-56.08%
2004-09-30โ‚น0.19 B144.02%
2003-09-30โ‚น80.3 M-20.19%
2002-09-30โ‚น0.10 B-11.58%
2001-09-30โ‚น0.11 B-76.8%
2000-09-30โ‚น0.49 B90.91%
1999-09-30โ‚น0.25 B-51.62%
1998-09-30โ‚น0.53 B319.22%
1997-09-30โ‚น0.12 B0.95%
1996-09-30โ‚น0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
โ‚น0.81 B 404.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น19.12 B 11,773.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น848.50 B 526,711.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น42.31 B 26,173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น197.90 B 122,776.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚น1.667 T 1,035,229.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น22.05 B 13,593.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.27 B 69.95%๐Ÿ‡บ๐Ÿ‡ธ USA